{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:12:44Z","timestamp":1781075564003,"version":"3.54.1"},"reference-count":40,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["PLACER-2020C3-21106"],"award-info":[{"award-number":["PLACER-2020C3-21106"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Millions of patients receive general anaesthesia for surgery annually. Crucial gaps in evidence exist regarding which technique, propofol total intravenous anaesthesia (TIVA) or inhaled volatile anaesthesia (INVA), yields superior patient experience, safety and outcomes. The aim of this pilot study is to assess the feasibility of conducting a large comparative effectiveness trial assessing patient experiences and outcomes after receiving propofol TIVA or INVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This protocol was cocreated by a diverse team, including patient partners with personal experience of TIVA or INVA. The design is a 300-patient, two-centre, randomised, feasibility pilot trial. Patients 18 years of age or older, undergoing elective non-cardiac surgery requiring general anaesthesia with a tracheal tube or laryngeal mask airway will be eligible. Patients will be randomised 1:1 to propofol TIVA or INVA, stratified by centre and procedural complexity. The feasibility endpoints include: (1) proportion of patients approached who agree to participate; (2) proportion of patients who receive their assigned randomised treatment; (3) completeness of outcomes data collection and (4) feasibility of data management procedures. Proportions and 95% CIs will be calculated to assess whether prespecified thresholds are met for the feasibility parameters. If the lower bounds of the 95% CI are above the thresholds of 10% for the proportion of patients agreeing to participate among those approached and 80% for compliance with treatment allocation for each randomised treatment group, this will suggest that our planned pragmatic 12 500-patient comparative effectiveness trial can likely be conducted successfully. Other feasibility outcomes and adverse events will be described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study is approved by the ethics board at Washington University (IRB# 202205053), serving as the single Institutional Review Board for both participating sites. Recruitment began in September 2022. Dissemination plans include presentations at scientific conferences, scientific publications, internet-based educational materials and mass media.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05346588\">NCT05346588<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-070096","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:46:04Z","timestamp":1681728364000},"page":"e070096","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Feasibility pilot trial for the Trajectories of Recovery after Intravenous propofol versus inhaled VolatilE anesthesia (THRIVE) pragmatic randomised controlled trial"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05346588","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-6434","authenticated-orcid":false,"given":"Bethany R","family":"Tellor Pennington","sequence":"first","affiliation":[{"name":"Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-9164","authenticated-orcid":false,"given":"Douglas A","family":"Colquhoun","sequence":"additional","affiliation":[{"name":"Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Neuman","sequence":"additional","affiliation":[{"name":"Anesthesiology & Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-6495","authenticated-orcid":false,"given":"Mary C","family":"Politi","sequence":"additional","affiliation":[{"name":"Surgery, Washington University in St. Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-5630","authenticated-orcid":false,"given":"Allison M","family":"Janda","sequence":"additional","affiliation":[{"name":"Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathie","family":"Spino","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Thelen-Perry","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenke","family":"Wu","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-5104","authenticated-orcid":false,"given":"Sathish S","family":"Kumar","sequence":"additional","affiliation":[{"name":"Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H","family":"Gregory","sequence":"additional","affiliation":[{"name":"Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Avidan","sequence":"additional","affiliation":[{"name":"Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kheterpal","sequence":"additional","affiliation":[{"name":"Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2025121605134974000_13.4.e070096.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60160-X"},{"key":"2025121605134974000_13.4.e070096.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-018-0632-3","article-title":"Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis","volume":"18","author":"Schraag","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"2025121605134974000_13.4.e070096.3","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002453"},{"key":"2025121605134974000_13.4.e070096.4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jclinane.2017.12.001","article-title":"A comparison between inhalational (desflurane) and total intravenous anaesthesia (propofol and dexmedetomidine) in improving postoperative recovery for morbidly obese patients undergoing laparoscopic sleeve gastrectomy: a double-blinded randomised controlled trial","volume":"45","author":"Elbakry","year":"2018","journal-title":"J Clin Anesth"},{"key":"2025121605134974000_13.4.e070096.5","article-title":"Total intravenous anaesthesia versus inhalational anaesthesia for adults undergoing transabdominal robotic assisted laparoscopic surgery","volume":"4","author":"Herling","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121605134974000_13.4.e070096.6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/anae.14456","article-title":"Taking on tiva. why we need guidelines on total intravenous anaesthesia","volume":"74","author":"Irwin","year":"2019","journal-title":"Anaesthesia"},{"key":"2025121605134974000_13.4.e070096.7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/anae.14428","article-title":"Guidelines for the safe practice of total intravenous anaesthesia (TIVA)","volume":"74","author":"Nimmo","year":"2019","journal-title":"Anaesthesia"},{"key":"2025121605134974000_13.4.e070096.8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2021.06.029","article-title":"Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty","volume":"138","author":"Chan","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2025121605134974000_13.4.e070096.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework","volume":"11","author":"Eldridge","year":"2016","journal-title":"PLOS ONE"},{"key":"2025121605134974000_13.4.e070096.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121605134974000_13.4.e070096.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000773","article-title":"Critical patient insights from the same-day feedback programme at Stanford health care","volume":"9","author":"Luna","year":"2020","journal-title":"BMJ Open Qual"},{"key":"2025121605134974000_13.4.e070096.12","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004489"},{"key":"2025121605134974000_13.4.e070096.13","unstructured":"U.S. Food and Drug Administration . Center for drug evaluation, research. sponsor responsibilities - safety reporting requirements and safety assessment for IND and bioavailability\/bioequivalence studies. n.d. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/sponsor-responsibilities-safety-reporting-requirements-and-safety-assessment-ind-and"},{"key":"2025121605134974000_13.4.e070096.14","unstructured":"Office for Human Research Protections (OHRP) . Unanticipated problems involving risks & adverse events guidance. 2007. Available: https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/guidance\/reviewing-unanticipated-problems\/index.html"},{"key":"2025121605134974000_13.4.e070096.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement Sci"},{"key":"2025121605134974000_13.4.e070096.16","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-8-12","article-title":"The use of interim data and data monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias","volume":"8","author":"Tharmanathan","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2025121605134974000_13.4.e070096.17","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1200\/JCO.1997.15.7.2736","article-title":"Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute","volume":"15","author":"Smith","year":"1997","journal-title":"J Clin Oncol"},{"key":"2025121605134974000_13.4.e070096.18","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(93)90002-U"},{"key":"2025121605134974000_13.4.e070096.19","doi-asserted-by":"publisher","DOI":"10.3310\/hta9400"},{"key":"2025121605134974000_13.4.e070096.20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamasurg.2016.4202","article-title":"Development and initial validation of the risk analysis index for measuring frailty in surgical populations","volume":"152","author":"Hall","year":"2017","journal-title":"JAMA Surg"},{"key":"2025121605134974000_13.4.e070096.21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bja.2017.11.013","article-title":"Systematic review of the qor-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesia","volume":"120","author":"Kleif","year":"2018","journal-title":"Br J Anaesth"},{"key":"2025121605134974000_13.4.e070096.22","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-3-124","article-title":"The diagnostic accuracy of the patient health questionnaire-2 (PHQ-2), patient health questionnaire-8 (PHQ-8), and patient health questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses","volume":"3","author":"Thombs","year":"2014","journal-title":"Syst Rev"},{"key":"2025121605134974000_13.4.e070096.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLR.0000093487.78664.3C"},{"key":"2025121605134974000_13.4.e070096.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026"},{"key":"2025121605134974000_13.4.e070096.25","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/42.6.535"},{"key":"2025121605134974000_13.4.e070096.26","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31826904a6"},{"key":"2025121605134974000_13.4.e070096.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707361"},{"key":"2025121605134974000_13.4.e070096.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100403"},{"key":"2025121605134974000_13.4.e070096.29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jhm.2418","article-title":"Preliminary development of an ultrabrief two-item bedside test for delirium","volume":"10","author":"Fick","year":"2015","journal-title":"J Hosp Med"},{"key":"2025121605134974000_13.4.e070096.30","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/jgs.16711","article-title":"Comparative accuracy and efficiency of four delirium screening protocols","volume":"68","author":"Motyl","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2025121605134974000_13.4.e070096.31","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.09.067231"},{"key":"2025121605134974000_13.4.e070096.32","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2016.1223177"},{"key":"2025121605134974000_13.4.e070096.33","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181b6267d"},{"key":"2025121605134974000_13.4.e070096.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2007.05055.x"},{"key":"2025121605134974000_13.4.e070096.35","article-title":"Propofol infusion syndrome in adults: a clinical update","volume":"2015","author":"Mirrakhimov","year":"2015","journal-title":"Crit Care Res Pract"},{"key":"2025121605134974000_13.4.e070096.36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anclin.2019.10.010","article-title":"Malignant hyperthermia update","volume":"38","author":"Ellinas","year":"2020","journal-title":"Anesthesiol Clin"},{"key":"2025121605134974000_13.4.e070096.37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.aan.2019.08.003","article-title":"Malignant hyperthermia: a clinical review","volume":"37","author":"Kim","year":"2019","journal-title":"Adv Anesth"},{"key":"2025121605134974000_13.4.e070096.38","doi-asserted-by":"publisher","DOI":"10.1159\/000339789"},{"key":"2025121605134974000_13.4.e070096.39","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3182a10e26"},{"key":"2025121605134974000_13.4.e070096.40","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000765"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-070096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:14:02Z","timestamp":1765890842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-070096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,17]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjopen-2022-070096"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-070096","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}